These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 14758448

  • 21. The spectrum of endemic renal tubular acidosis in the northeast of Thailand.
    Vasuvattakul S, Nimmannit S, Chaovakul V, Susaengrat W, Shayakul C, Malasit P, Halperin ML, Nilwarangkur S.
    Nephron; 1996; 74(3):541-7. PubMed ID: 8938678
    [Abstract] [Full Text] [Related]

  • 22. Abnormal distal renal tubular acidification in patients with low bone mass: prevalence and impact of alkali treatment.
    Sromicki JJ, Hess B.
    Urolithiasis; 2017 Jun; 45(3):263-269. PubMed ID: 27412028
    [Abstract] [Full Text] [Related]

  • 23. Urine acidification capacity in renal stone formers.
    Backman U, Danielson BG, Sohtell M.
    Scand J Urol Nephrol; 1976 Jun; Suppl 35():49-61. PubMed ID: 26969
    [Abstract] [Full Text] [Related]

  • 24. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL, Nakagawa Y, Asplin J, Parks JH.
    Miner Electrolyte Metab; 1994 Jun; 20(6):378-84. PubMed ID: 7783700
    [Abstract] [Full Text] [Related]

  • 25. [The significance of citrate, uromucoid and GAG for diagnosis of renal tubular acidosis in patients with urinary calculi].
    Bichler KH, Henzler B, Strohmaier WL, Stahl C, Korn S.
    Urologe A; 1995 Nov; 34(6):437-43. PubMed ID: 8848853
    [Abstract] [Full Text] [Related]

  • 26. Prospective long-term evaluation of incomplete distal renal tubular acidosis in idiopathic calcium nephrolithiasis diagnosed by low-dose NH4CL loading - gender prevalences and impact of alkali treatment.
    Sromicki J, Kacl G, Föhl M, Hess B.
    J Nephrol; 2022 Jul; 35(6):1619-1626. PubMed ID: 34973150
    [Abstract] [Full Text] [Related]

  • 27. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B.
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [Abstract] [Full Text] [Related]

  • 28. Role of urinary inhibitors of crystallization in uric acid nephrolithiasis: Dalmatian dog model.
    Carvalho M, Lulich JP, Osborne CA, Nakagawa Y.
    Urology; 2003 Sep; 62(3):566-70. PubMed ID: 12946778
    [Abstract] [Full Text] [Related]

  • 29. Defective urinary crystallization inhibition and urinary stone formation.
    Carvalho M, Lulich JP, Osborne CA, Nakagawa Y.
    Int Braz J Urol; 2006 Sep; 32(3):342-8; discussion 349. PubMed ID: 16813682
    [Abstract] [Full Text] [Related]

  • 30. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R, Vescini F.
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [Abstract] [Full Text] [Related]

  • 31. Renal acidification defects in patients with recurrent calcium nephrolithiasis.
    Tessitore N, Ortalda V, Fabris A, D'Angelo A, Rugiu C, Oldrizzi L, Lupo A, Valvo E, Gammaro L, Loschiavo C.
    Nephron; 1985 Sep; 41(4):325-32. PubMed ID: 4069301
    [Abstract] [Full Text] [Related]

  • 32. Acid-base metabolism: implications for kidney stones formation.
    Hess B.
    Urol Res; 2006 Apr; 34(2):134-8. PubMed ID: 16411127
    [Abstract] [Full Text] [Related]

  • 33. Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers.
    Dhayat NA, Gradwell MW, Pathare G, Anderegg M, Schneider L, Luethi D, Mattmann C, Moe OW, Vogt B, Fuster DG.
    Clin J Am Soc Nephrol; 2017 Sep 07; 12(9):1507-1517. PubMed ID: 28775126
    [Abstract] [Full Text] [Related]

  • 34. Nephrolithiasis in renal tubular acidosis.
    Buckalew VM.
    J Urol; 1989 Mar 07; 141(3 Pt 2):731-7. PubMed ID: 2645431
    [Abstract] [Full Text] [Related]

  • 35. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, Grynpas MD, Bushinsky DA.
    J Am Soc Nephrol; 2015 Dec 07; 26(12):3001-8. PubMed ID: 25855777
    [Abstract] [Full Text] [Related]

  • 36. Complete distal renal tubular acidosis in systemic lupus: clinical and laboratory findings.
    Caruana RJ, Barish CF, Buckalew VM.
    Am J Kidney Dis; 1985 Jul 07; 6(1):59-63. PubMed ID: 4025329
    [Abstract] [Full Text] [Related]

  • 37. Characterization of Ca(2+)-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin using vanadyl ions: different metal binding properties in strong and weak inhibitor proteins revealed by EPR and ENDOR.
    Mustafi D, Nakagawa Y.
    Biochemistry; 1996 Nov 26; 35(47):14703-9. PubMed ID: 8942630
    [Abstract] [Full Text] [Related]

  • 38. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO, Wipplinger J.
    Eur J Med Res; 2008 Jul 28; 13(7):332-42. PubMed ID: 18700191
    [Abstract] [Full Text] [Related]

  • 39. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
    Nakagawa Y, Ahmed M, Hall SL, Deganello S, Coe FL.
    J Clin Invest; 1987 Jun 28; 79(6):1782-7. PubMed ID: 3584470
    [Abstract] [Full Text] [Related]

  • 40. Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis.
    Dessombz A, Letavernier E, Haymann JP, Bazin D, Daudon M.
    J Urol; 2015 May 28; 193(5):1564-9. PubMed ID: 25498572
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.